Paul Gama Archives - CDR – Chain Drug Review

CHPA names P&G’s Paul Gama as board chair

April 14, 2020 by Chain Drug Review Paul Gama, Scott Melville, The Consumer Healthcare Products Association (CHPA) Leading Headlines, Supplier News

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced on Tuesday the appointment of Paul Gama as the new chair of the CHPA board of directors. Gama was elected on April 13, 2020, along with other new board members, at CHPA’s annual membership meeting conducted, for the first time ever, in a virtual forum online.

CHPA welcomes new board members

November 15, 2018 by Chain Drug Review Consumer Healthcare Products Association (CHPA), Gary Downing, Patrick Lockwood-Taylor, Paul Gama, Scott Melville Leading Headlines

WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America